Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. The BUY prediction by JPMorgan_Chase___Co_ for Abbott Laboratories closed nearly unchanged. JPMorgan_Chase___Co_ has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €1.96 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Abbott Laboratories | 3.068% | 3.068% | -15.894% | -11.218% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten